Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Stable hemoglobin in hemodialysis patients: forest for the trees--a 12-week pilot observational study.

Rottembourg JB, Kpade F, Tebibel F, Dansaert A, Chenuc G.

BMC Nephrol. 2013 Nov 4;14:243. doi: 10.1186/1471-2369-14-243.

PMID:
24180578
[PubMed - indexed for MEDLINE]
Free Article
2.

[Feasibility strategy of darbepoetin alfa administration every other week: 2005-2007 experience in a dialysis unit].

Rottembourg JB, Dansaert A.

Nephrol Ther. 2011 Dec;7(7):549-57. doi: 10.1016/j.nephro.2011.03.011. Epub 2011 May 31. French.

PMID:
21622039
[PubMed - indexed for MEDLINE]
3.

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

Feriani M, De Meester JM, McMahon LP, Rottembourg JB, Bridges I, Farouk M, Pronai W.

BMC Nephrol. 2011 Mar 24;12:13. doi: 10.1186/1471-2369-12-13.

PMID:
21435267
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

An observational study of the effectiveness of darbepoetin alpha administered in dialysis patients once every 2 weeks for 12 months.

Rottembourg JB, Bridges I, Pronai W, Feriani M, McMahon LP, De Meester JM, Farouk M, Molemans B.

Clin Nephrol. 2011 Mar;75(3):242-50.

PMID:
21329635
[PubMed - indexed for MEDLINE]
5.

Thrombocytopenia induced by nicotinamide in hemodialysis patients.

Rottembourg JB, Launay-Vacher V, Massard J.

Kidney Int. 2005 Dec;68(6):2911-2. No abstract available.

PMID:
16316377
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk